Salva Katrin A, Bennett Daniel, Longley Jack, Guitart Joan, Wood Gary S
*Department of Dermatology, University of Wisconsin; and †Department of Dermatology, Northwestern University.
Am J Dermatopathol. 2015 Oct;37(10):e116-21. doi: 10.1097/DAD.0000000000000323.
Expression of the pan B-cell marker CD20 by T-cell lymphoproliferative disorders is exceedingly rare. We present a 52-year-old man with a unilesional cutaneous CD20 T-cell lymphoproliferative disorder. Multispectral imaging analysis of CD3-CD20 double-stained lesional tissue sections allowed (1) the visualization of double-positive T lymphocytes in situ with sensitivity superior to that of conventional immunohistochemistry and (2) the quantitative assessment of marker coexpression. Here, 23% of CD3 signals in the patient's lesion were also CD20, whereas 38% of CD20 signals were also CD3. In contrast, both parameters were below 1% in the tonsil control. Overall, the percentage of double-positive cells in lesional skin was 35%, although only 0.4% of such cells were detected in the tonsil. This is the first demonstration of aberrant CD20 expression by skin-infiltrating T cells using multispectral imaging.
T细胞淋巴增殖性疾病表达泛B细胞标志物CD20极为罕见。我们报告了一名52岁男性,患有单病灶皮肤CD20 T细胞淋巴增殖性疾病。对CD3-CD20双重染色的病灶组织切片进行多光谱成像分析,(1)可在原位可视化双阳性T淋巴细胞,其灵敏度优于传统免疫组织化学;(2)可对标志物共表达进行定量评估。在此病例中,患者病灶中23%的CD3信号也为CD20,而38%的CD20信号也为CD3。相比之下,扁桃体对照中这两个参数均低于1%。总体而言,病灶皮肤中双阳性细胞的百分比为35%,而扁桃体中仅检测到0.4%的此类细胞。这是首次使用多光谱成像证明皮肤浸润T细胞异常表达CD20。